Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Google.... Cannabis Versus Opioids For Pain

<< Previous

Bullboard Posts

Next >>

Comment by Realnewsalways1on Jul 06, 2022 11:31am

95 Views

Post# 34805072

RE:Google.... Cannabis Versus Opioids For Pain

have you not seen the preliminary results of Reborn? All positive in head to head with Opiod use. That is very compelling and fact. There is no disputing this and cant spin as you do. The down side is the recruiting and partnering in Australia will alleviate this issue. The reason is that they are a CRO and it is in their best interest to have this a success.

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market